Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Heart, Vascular and Thoracic

22-HVI-2903977_ex-vivo-lung-perfusion_650x450

High Donor Lung Weight Likelier to Lead to Poor Transplant Outcomes

A call to use lung weight in assessing need for EVLP, transplant suitability

Scientist Pointing at Computer Screen

How MedStar Health Has Successfully Integrated Cardiovascular Quality Processes Across Multiple Sites

Standardized practices from registries to quality meetings yield efficiencies and value

22-HVI-2770308 CQD 650×450

A New Take on Heart Failure: Emerging Interventional Approaches

Snapshots of four interventional therapies in clinical testing

Bariatric surgery
April 12, 2022/Digestive

Bariatric Surgery for Obesity at Age 65 and Beyond: A Cardiovascular Win

Medicare database analysis finds reduced risk of death, heart failure, myocardial infarction and stroke

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Scott Cameron, MD, PhD

Platelet Olfactory Receptor Identified as Possible AAA Biomarker and Treatment Target

Investigations on platelet/aneurysm interactions lead to $2.6 million NIH grant

22-HVI-2843464_transcatheter-bicaval-valves-system_650x450

First Transcatheter TricValve System Implanted for Tricuspid Regurgitation in North America

FDA-designated breakthrough device offers first treatment option for severe TR and right HF

Desai, MD

Mavacamten Significantly Reduces Patients’ Need for Septal Reduction Therapy Over 16 Weeks

Longer-term confirmation of VALOR-HCM could yield a noninvasive therapy for severe obstructive HCM

22-HVI-2769711_lipoprotein(a)_650x450

Novel siRNA Therapy Lowers Elevated Plasma Lipoprotein(a) in Phase 1 APOLLO Trial

Targeted mRNA blocking could be first effective approach specific to this cardiovascular risk factor

22-HVI-2828108_dual-chamber-leadless-pacemaker_650x450

Clinical Trial of First Dual-Chamber Leadless Pacemaker Underway

First U.S. implant at Cleveland Clinic signals another key shift away from transvenous leads

22-HVI-2768410_mitraclip_650x450

PRIMARY Trial Aims to Guide Choice of Percutaneous Vs. Surgical Repair of Degenerative Mitral Regurgitation

Essentials of the NIH study and how it compares with REPAIR MR

BackPage 26 of 82Next

Advertisement

Ad